RANDOMISED PLACEBO CONTROLLED PILOT STUDY ON COMPARING RED CLOVER (P-07) VERSUS PLACEBO FOR THE TREATMENT OF PREMENSTRUAL SYNDROME

Maturitas ◽  
2009 ◽  
Vol 63 ◽  
pp. S114-S115 ◽  
Author(s):  
S. Taher ◽  
A. Cahill ◽  
J. Eliahoo ◽  
M. Calvin ◽  
C. Rothon ◽  
...  
Keyword(s):  
Pilot Study ◽  
Premenstrual Syndrome ◽  
Red Clover

scholarly journals Insulin Sensitivity, Food Intake, and Cravings with Premenstrual Syndrome: A Pilot Study

2008 ◽  
Vol 17 (4) ◽  
pp. 657-665 ◽  
Author(s):  
Kimberly K. Trout ◽  
Lisa Basel-Brown ◽  
Michael R. Rickels ◽  
Mark H. Schutta ◽  
Maja Petrova ◽  
...  
Keyword(s):  
Insulin Sensitivity ◽  
Pilot Study ◽  
Food Intake ◽  
Premenstrual Syndrome

PREMENSTRUAL SYNDROME IN WOMEN WITH MENTAL HANDICAP: A PILOT STUDY

1993 ◽  
Vol 39 (77) ◽  
pp. 104-107 ◽  
Author(s):  
M. Ghaziuddin ◽  
T.E. Elkins ◽  
S.G. McNeeley ◽  
N. Ghaziuddin
Keyword(s):  
Pilot Study ◽  
Premenstrual Syndrome ◽  
Mental Handicap

A Pilot Study to Compare Fluoxetine, Calcium, and Placebo in the Treatment of Premenstrual Syndrome

2013 ◽  
Vol 33 (5) ◽  
pp. 614-620 ◽  
Author(s):  
Kimberly Ann Yonkers ◽  
Teri B. Pearlstein ◽  
Nathan Gotman
Keyword(s):  
Pilot Study ◽  
Premenstrual Syndrome

scholarly journals Absorption of red clover isoflavones in human subjects: results from a pilot study

2010 ◽  
Vol 103 (11) ◽  
pp. 1569-1572 ◽  
Author(s):  
Ronald Maul ◽  
Sabine E. Kulling
Keyword(s):  
Single Dose ◽  
Plasma Concentration ◽  
Pilot Study ◽  
Enzymatic Hydrolysis ◽  
Human Subjects ◽  
Plasma Concentrations ◽  
Red Clover ◽  
First Time ◽  
High Bioavailability ◽  
Present Pilot Study

In addition to soya-derived preparations, red clover-based dietary supplements have gained considerable interest as an alternative isoflavone (IF) source. While metabolism and bioavailability of the main IF from both sources have already been investigated, studies are still lacking on the biokinetic behaviour of IF, which are present in red clover in minor amounts. In the present pilot study, in which seven volunteers ingested a single dose of a commercial red clover dietary supplement, we focused on the absorption of three such IF, irilone (IRI), prunetin (PRUN) and pseudobaptigenin (PBAP). The compounds were measured as aglycones after enzymatic hydrolysis. A single intake of an amount of as low as 3·8 mg IRI (out of 38·8 mg IF in total) resulted in an IRI plasma concentration of 0·35 (sd 0·16) μm at 6.5 h post-ingestion. Compared to the plasma concentrations found for daidzein (0·39 μm) and genistein (0·06 μm), expected to be the main IF metabolites in plasma, the present findings indicate that IRI might possess a relatively high bioavailability. Furthermore, PRUN and PBAP were detected in human plasma for the first time.

Sign in / Sign up

Export Citation Format

Share Document